figshare
Browse

odistr-clinical-evidence

Version 3 2025-10-16, 13:30
Version 2 2025-09-15, 17:08
Version 1 2025-09-15, 16:51
preprint
posted on 2025-10-16, 13:30 authored by Rajatsubhra MukhopadhyayRajatsubhra Mukhopadhyay
<p dir="ltr">Clinical evidence and case reports supporting ODISTR (On Demand INTRANASAL STEROID THERAPY of Rajatsubhra) for pediatric allergic and wheezy conditions. Includes guardian consent, long-term follow-up, and treatment protocols.</p><p dir="ltr"> > Clinical evidence and case reports supporting ODISTR (On Demand INTRANASAL STEROID THERAPY of Rajatsubhra) for pediatric allergic and wheezy conditions. This dataset includes guardian consent forms, long-term follow-up records, and treatment outcomes demonstrating safety, feasibility, and effectiveness of this non-invasive approach. Developed at Child Health Care Arambag (CHCA) [Wikidata: Q135493189], with institutional support from Sri Yoga Center Trust – Kunarpur [Wikidata: Q135898418]. All research is self-funded by Dr. Rajatsubhra Mukhopadhyay (ORCID: 0000-0001-5658-8016) with the intention to promote low-cost, patient-friendly innovation for global child health.</p><p dir="ltr"><br></p>

Funding

This research, self-funded by Dr. Rajatsubhra Mukhopadhyay (ORCID: 0000-0001-5658-8016), aims to establish ODISTR (On-Demand Intranasal Steroid Therapy) as a low-cost, patient-friendly, and globally adaptable innovation for pediatric asthma and allergy management.

History